Crinetics Pharmaceuticals, Inc. (CRNX) Max Pain Analysis

Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.

Crinetics Pharmaceuticals, Inc. (CRNX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $3.95B, listed on NASDAQ, employing roughly 437 people, carrying a beta of 0.28 to the broader market. Crinetics Pharmaceuticals, Inc. Led by R. Scott Struthers, public since 2018-07-18.

Snapshot as of May 15, 2026.

Spot Price
$36.58
Total OI
2.5K

Learn how max pain is reported and how to read the data →